Monnet Isabelle

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The median age of newly diagnosed patients with non-small cell lung cancer (NSCLC) is 67 years, and one-third of patients are older than 75 years. Elderly patients are more vulnerable to the adverse effects of chemotherapy, and targeted therapy might thus be a relevant alternative. The objective of this study was to assess the cost-effectiveness of(More)
  • 1